ACOR
Acorda Therapeutics, Inc.
NasdaqGS
People also watch:ALNYAMAGACADMDVNBMRN
26.110.51 (1.99%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close25.60
Open25.67
Bid26.09 x 200
Ask26.12 x 200
52wk Range23.85 - 43.63
Day's Range25.45 - 26.22
Volume170,149
Avg Vol (3m)543,038
As of 3:36 PM EDT. NasdaqGS Real Time Price. Market open.
  • 7 Biotech Stocks that are Buys Right Now
    Zackslast month

    7 Biotech Stocks that are Buys Right Now

    Buy these seven biotech stocks now and see how well the second half of 2016 unfolds for this industry.

  • Acorda Therapeutics, Inc. – Value Analysis (NASDAQ:ACOR) : June 13, 2016
    Capital Cubelast month

    Acorda Therapeutics, Inc. – Value Analysis (NASDAQ:ACOR) : June 13, 2016

    Click here to see latest analysisCapitalcube gives Acorda Therapeutics, Inc. a score of 56.Our analysis is based on comparing Acorda Therapeutics, Inc. with the following peers – Repligen Corporation, BioMarin Pharmaceutical Inc., Momenta Pharmaceuticals, Inc. and Mylan N.V. (RGEN-US, BMRN-US, MNTA-US and MYL-US).Investment OutlookAcorda Therapeutics, Inc. has a fundamental score of 56 and has a […] (Read more...) The post Acorda Therapeutics, Inc. – Value Analysis (NASDAQ:ACOR) : June 13, 2016 appeared first on CapitalCube.